Genocea Biosciences, Inc. was founded in 2013 as a biopharmaceutical company focusing on the development of new drugs that utilize the body's natural anti-inflammatory and anti-cancer defense mechanisms. The company has developed the PENTARAY Target Discovery Platform, which can access the pool of epitopes recognized by the human immune system to select multiple therapeutic targets for its candidate vaccines and for inhibiting T-cell disfunction associated with infectious diseases.
